Craft

NanoString

Stock Price

$0.1

2024-09-17

Market Capitalization

$5.1 M

2024-09-17

Revenue

$127.3 M

FY, 2022

NanoString Summary

Company Summary

Overview
NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics. The company offers three platforms: nCounter Analysis System, that allows researchers to profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations; GeoMx Digital Spatial Profiler that enables multiplexed spatial profiling of RNA and protein targets in various sample types; and CosMx Spatial Molecular Imager that enables high-resolution imaging of RNAs or proteins directly from single cells within morphologically intact whole tissue sections.
Type
Public
Status
Active
Founded
2003
HQ
Seattle, WA, US | view all locations
Website
https://nanostring.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Brad Gray

    Brad Gray, President, CEO & Director

  • Joseph M. Beechem

    Joseph M. Beechem, Chief Scientific Officer & Senior Vice President, Research & Development

  • K. Thomas Bailey

    K. Thomas Bailey, Chief Financial Officer

  • William D. Young, Chairman of the Board

    Operating MetricsView all

    Patents (US)

    34
    8.1%

    Q2, 2022

    Scientific Collaborations

    3

    FY, 2021

    Projects Completed to Date (Technology Access Program)

    920
    53.3%

    Q2, 2022

    LocationsView all

    2 locations detected

    • Seattle, WA HQ

      United States

      530 Fairview Ave N

    • Amsterdam, NH

      Netherlands

      Paasheuvelweg 25

    NanoString Financials

    Summary Financials

    Revenue (Q3, 2023)
    $48.1M
    Gross profit (Q3, 2023)
    $17.4M
    Net income (Q3, 2023)
    ($37.4M)
    Cash (Q3, 2023)
    $93.8M
    EBIT (Q3, 2023)
    ($36.5M)
    Enterprise value
    $159.0M

    Footer menu